Quest Diagnostics Buys Blueprint Genetics to Help It Read Mountains of DNA Data

Quest Diagnostics (NYSE: DGX) runs medical tests on one in three American adults each year, and there are treasure chests full of medical insights buried in the mountains of genetic data some of those tests generate. To help analyze and interpret all the sequenced genetic data that piles up, Quest recently acquired a privately held company called Blueprint Genetics for an undisclosed sum.

Quest Diagnostics is best known for processing the most commonly performed laboratory tests, but it has lots of capable competition in that niche, a condition that can quickly squeeze profit margins. So it's rapidly building a slate of next-generation DNA sequencing services to add to its menu of advanced diagnostic services; Blueprint will give it a greater capacity to interpret the results.

Image source: Getty Images.

Source Fool.com